PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2007 | 56 | 3-4 | 227-232
Article title

Własność intelektualna i biotechnologia oraz nowe leki

Content
Title variants
EN
Intelectual property rights, biotechnology and innovative medicines
Languages of publication
PL EN
Abstracts
EN
Intellectual property rights (IPR) are the main requirement of the implementation of inventions. The IPR system in Central Europe (CE) has some specificity in comparison to the "old EU 15". The key contribution of the research-based pharmaceutical industry to medical progress is to turn fundamental research findings into innovative and commonly accessible treatments. The creation of an innovative medicine requires a strong research organization and accumulation of enormous financial resources. Counterparts of innovative medicines the protection of which has expired are generic medicines. All of the CE states now offer product patents, but the IPR regulations were introduced in the early 1990s. One of the most important issues for pharmaceutics in the EU expansion concerns intellectual property protection.
Keywords
Journal
Year
Volume
56
Issue
3-4
Pages
227-232
Physical description
Dates
published
2007
Contributors
  • Biuro Patentów i Znaków Towarowych Jan Wierzchon & Partnerzy, Żurawia 47/49, 00-680 Warszawa, Polska
References
  • USTAWA z dn. 30 czerwca 2000. Prawo własności przemysłowej. Dz. U. 119 poz. 1117, z późn. Zmianami.
  • Filipiak K., 2002. Leki oryginalne a generyczne. Meritum 3, Okręgowa Rada Lekarska w Toruniu.
  • Grzesiczak M., 2005. Koszty procedury zgłoszeniowej w trybie PCT. Nowator 21, 12-13.
  • Kaliszan R., Janicki S., 2001. Biorównoważ ność leków. Farm. Pol. 57, 456-462.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-ksv56p227kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.